Kingworld Medicines Group Limited (1110.HK)
HKD 0.45
(1.12%)
HKD 0.45
(1.12%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 354.42 Million CNY | 21.93% |
| 2022 | 290.67 Million CNY | 21.64% |
| 2021 | 238.95 Million CNY | -21.85% |
| 2020 | 305.77 Million CNY | 31.91% |
| 2019 | 231.81 Million CNY | -31.15% |
| 2018 | 336.67 Million CNY | -18.48% |
| 2017 | 412.98 Million CNY | -3.08% |
| 2016 | 426.1 Million CNY | 148.15% |
| 2015 | 171.71 Million CNY | -24.91% |
| 2014 | 228.67 Million CNY | 132.45% |
| 2013 | 98.37 Million CNY | 60.96% |
| 2012 | 61.12 Million CNY | 29.58% |
| 2011 | 47.16 Million CNY | -76.16% |
| 2010 | 197.84 Million CNY | -35.47% |
| 2009 | 306.6 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 375.46 Million CNY | 3.45% |
| 2024 Q1 | 375.46 Million CNY | 5.93% |
| 2023 Q3 | 348.06 Million CNY | 14.97% |
| 2023 Q4 | 354.42 Million CNY | 1.83% |
| 2023 FY | 354.42 Million CNY | 21.93% |
| 2023 Q1 | 294.79 Million CNY | 1.42% |
| 2023 Q2 | 302.73 Million CNY | 2.69% |
| 2022 Q3 | 282.67 Million CNY | 14.71% |
| 2022 Q1 | 238.16 Million CNY | -0.33% |
| 2022 Q4 | 290.67 Million CNY | 2.83% |
| 2022 FY | 290.67 Million CNY | 21.64% |
| 2022 Q2 | 246.41 Million CNY | 3.47% |
| 2021 FY | 238.95 Million CNY | -21.85% |
| 2021 Q4 | 238.95 Million CNY | 3.28% |
| 2021 Q3 | 231.37 Million CNY | -15.91% |
| 2021 Q2 | 275.14 Million CNY | 3.06% |
| 2021 Q1 | 266.95 Million CNY | -12.69% |
| 2020 Q4 | 305.77 Million CNY | 2.69% |
| 2020 Q3 | 297.77 Million CNY | -27.01% |
| 2020 Q1 | 398.47 Million CNY | 71.89% |
| 2020 Q2 | 407.96 Million CNY | 2.38% |
| 2020 FY | 305.77 Million CNY | 31.91% |
| 2019 Q1 | 279.32 Million CNY | -17.04% |
| 2019 FY | 231.81 Million CNY | -31.15% |
| 2019 Q2 | 285.89 Million CNY | 2.35% |
| 2019 Q4 | 231.81 Million CNY | 4.09% |
| 2019 Q3 | 222.7 Million CNY | -22.1% |
| 2018 Q3 | 336.67 Million CNY | -2.69% |
| 2018 Q2 | 345.98 Million CNY | 0.0% |
| 2018 Q1 | 345.98 Million CNY | -16.22% |
| 2018 FY | 336.67 Million CNY | -18.48% |
| 2018 Q4 | 336.67 Million CNY | 0.0% |
| 2017 Q1 | 316.06 Million CNY | -25.82% |
| 2017 Q4 | 412.98 Million CNY | 0.0% |
| 2017 Q3 | 412.98 Million CNY | 41.88% |
| 2017 Q2 | 291.06 Million CNY | -7.91% |
| 2017 FY | 412.98 Million CNY | -3.08% |
| 2016 Q2 | 297.41 Million CNY | 0.0% |
| 2016 FY | 426.1 Million CNY | 148.15% |
| 2016 Q4 | 426.1 Million CNY | 0.0% |
| 2016 Q3 | 426.1 Million CNY | 43.27% |
| 2016 Q1 | 297.41 Million CNY | 73.2% |
| 2015 Q3 | 171.71 Million CNY | -55.11% |
| 2015 Q1 | 382.55 Million CNY | 67.29% |
| 2015 Q2 | 382.55 Million CNY | 0.0% |
| 2015 FY | 171.71 Million CNY | -24.91% |
| 2015 Q4 | 171.71 Million CNY | 0.0% |
| 2014 Q1 | 154.53 Million CNY | 57.08% |
| 2014 Q4 | 228.67 Million CNY | -4.43% |
| 2014 Q3 | 239.28 Million CNY | 54.84% |
| 2014 FY | 228.67 Million CNY | 132.45% |
| 2014 Q2 | 154.53 Million CNY | 0.0% |
| 2013 Q2 | 58.54 Million CNY | 0.0% |
| 2013 Q4 | 98.37 Million CNY | 0.0% |
| 2013 FY | 98.37 Million CNY | 60.96% |
| 2013 Q1 | 58.54 Million CNY | -4.22% |
| 2013 Q3 | 98.37 Million CNY | 68.05% |
| 2012 Q3 | - CNY | -100.0% |
| 2012 FY | 61.12 Million CNY | 29.58% |
| 2012 Q4 | 61.12 Million CNY | 0.0% |
| 2012 Q2 | 30.11 Million CNY | 0.0% |
| 2011 FY | 47.16 Million CNY | -76.16% |
| 2011 Q2 | 78.99 Million CNY | 0.0% |
| 2011 Q4 | 47.16 Million CNY | 0.0% |
| 2010 Q4 | 197.84 Million CNY | 0.0% |
| 2010 FY | 197.84 Million CNY | -35.47% |
| 2009 FY | 306.6 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| China Healthwise Holdings Limited | 108.9 Million HKD | -225.46% |
| Tycoon Group Holdings Limited | 206.16 Million HKD | -71.918% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 131.81 Million HKD | -168.885% |